Share Facebook Twitter LinkedIn Pinterest Email Key deals this week: Protagonist Therapeutics, Bristol Myers, Novo Nordisk, Fifth Third Bancorp and more
Knowles forecasts Q2 2026 EPS of $0.28 to $0.32 as Precision Devices ramps energy order by end of Q2 (NYSE:KN)April 24, 2026